A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1658
Last updated 2016-03-14
Summary
To describe the current treatment practice during 12 months for previously treated patients diagnosed with haemophilia A or haemophilia B.
Conditions
- Haemophilia A
- Haemophilia B
Sponsors & Collaborators
-
Swedish Orphan Biovitrum
lead INDUSTRY
Principal Investigators
-
Stefan Lethagen, MD · Swedish Orphan Biovitrum AB (publ)
Eligibility
- Min Age
- 2 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- Belgium
- France
- Germany
- Italy
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
NCT00927667 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
NCT04583930 ·Status: UNKNOWN
-
Sonography and Haemophilia
NCT04550988 ·Status: UNKNOWN
-
Long-term Anticoagulation in a Patient With Severe Hemophilia A
NCT07314983 ·Status: RECRUITING
-
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
NCT03276130 ·Status: COMPLETED
-
Treatment of Hemophilia A Patients With FVIII Inhibitors
NCT04023019 ·Status: RECRUITING
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542 ·Status: RECRUITING
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting
NCT00950170 ·Status: COMPLETED ·Phase: PHASE4
-
Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
NCT02256917 ·Status: COMPLETED ·Phase: PHASE3
-
Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
NCT00995046 ·Status: TERMINATED ·Phase: NA
-
Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia
NCT03299699 ·Status: COMPLETED
-
Joint Outcome Study
NCT00207597 ·Status: COMPLETED
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
NCT02476942 ·Status: COMPLETED
-
rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors
NCT01105546 ·Status: UNKNOWN ·Phase: PHASE2
-
Bleeding Symptoms of Carriers of Hemophilia A and B
NCT01029808 ·Status: COMPLETED
-
Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination
NCT04133883 ·Status: COMPLETED ·Phase: NA
-
Learning to Live With Non-severe Haemophilia
NCT05314751 ·Status: COMPLETED
-
Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia
NCT07099313 ·Status: RECRUITING
-
Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
NCT00243659 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A
NCT01811875 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
NCT00782470 ·Status: COMPLETED
-
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
NCT03695978 ·Status: RECRUITING